Literature DB >> 8335136

Different biomechanical properties of human fetal membranes obtained before and after delivery.

R Helmig1, H Oxlund, L K Petersen, N Uldbjerg.   

Abstract

The aim of this study was to elucidate whether the mechanical properties of fetal membranes change during late pregnancy and labour. Membranes delivered by elective caesarean section in week 38 showed different load-strain curves to membranes obtained after spontaneous vaginal delivery at term. A major change in mechanical properties was a decrease in strength of the intact chorioamniotic membrane from 1.39 N to 0.98 N (width of biopsy 4 mm), mainly due to loss of strength of the amniotic component, from 1.27 N to 0.72 N. Moreover, the extensibility of the chorionic component (epsilon Fmax) increased after vaginal delivery from 0.42 to 0.54, resulting in a two-component behaviour of the intact chorioamniotic membrane and further decrease of strength. Based on these observations it is suggested that the amnion is attached to the chorion, act biomechanically in parallel and possess relatively high mechanical strength during pregnancy. After vaginal delivery the two membranes are separated, and pronounced changes are induced in their mechanical properties.

Entities:  

Mesh:

Year:  1993        PMID: 8335136     DOI: 10.1016/0028-2243(93)90086-r

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  14 in total

1.  Uniaxial stress-relaxation and stress-strain responses of human amnion.

Authors:  Michelle L Oyen; Steven E Calvin; Robert F Cook
Journal:  J Mater Sci Mater Med       Date:  2004-05       Impact factor: 3.896

Review 2.  Extracellular matrix dynamics and fetal membrane rupture.

Authors:  Jerome F Strauss
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

3.  On the defect tolerance of fetal membranes.

Authors:  Kevin Bircher; Alexander E Ehret; Deborah Spiess; Martin Ehrbar; Ana Paula Simões-Wüst; Nicole Ochsenbein-Kölble; Roland Zimmermann; Edoardo Mazza
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

4.  Amniotic membrane attenuates heterotopic ossification following high-dose bone morphogenetic protein-2 treatment of segmental bone defects.

Authors:  Lauren B Priddy; Laxminarayanan Krishnan; Marian H Hettiaratchi; Sukhita Karthikeyakannan; Nikhil Gupte; Robert E Guldberg
Journal:  J Orthop Res       Date:  2022-03-27       Impact factor: 3.102

5.  Decreased adherence and spontaneous separation of fetal membrane layers--amnion and choriodecidua--a possible part of the normal weakening process.

Authors:  A Strohl; D Kumar; R Novince; P Shaniuk; J Smith; K Bryant; R M Moore; J Novak; B Stetzer; B M Mercer; J M Mansour; J J Moore
Journal:  Placenta       Date:  2009-11-17       Impact factor: 3.481

6.  Mechanical failure of human fetal membrane tissues.

Authors:  Michelle L Oyen; Robert F Cook; Steven E Calvin
Journal:  J Mater Sci Mater Med       Date:  2004-06       Impact factor: 3.896

Review 7.  Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity.

Authors:  E A Anum; L D Hill; A Pandya; J F Strauss
Journal:  Placenta       Date:  2009-01-18       Impact factor: 3.481

Review 8.  Biomechanics of the fetal membrane prior to mechanical failure: review and implications.

Authors:  Erinn M Joyce; John J Moore; Michael S Sacks
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-03-19       Impact factor: 2.435

9.  Function and failure of the fetal membrane: Modelling the mechanics of the chorion and amnion.

Authors:  Stefaan W Verbruggen; Michelle L Oyen; Andrew T M Phillips; Niamh C Nowlan
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

10.  Connexin 43 is overexpressed in human fetal membrane defects after fetoscopic surgery.

Authors:  David W Barrett; Anna L David; Christopher Thrasivoulou; Alvaro Mata; David L Becker; Alex C Engels; Jan A Deprest; Tina T Chowdhury
Journal:  Prenat Diagn       Date:  2016-09-25       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.